Welcome to LookChem.com Sign In|Join Free
  • or
3(2H)-Pyridazinone,4,5-dihydro-5-(hydroxymethyl)-6-[4-(4-morpholinyl)-3-nitrophenyl]- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

102625-17-2

Post Buying Request

102625-17-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

102625-17-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 102625-17-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,2,6,2 and 5 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 102625-17:
(8*1)+(7*0)+(6*2)+(5*6)+(4*2)+(3*5)+(2*1)+(1*7)=82
82 % 10 = 2
So 102625-17-2 is a valid CAS Registry Number.

102625-17-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name 6-(3-nitro-4-morpholino-phenyl)-5-hydroxymethyl-4,5-dihydro-3(2H)-pyridazinone

1.2 Other means of identification

Product number -
Other names 5-Hydroxymethyl-6-(4-morpholin-4-yl-3-nitro-phenyl)-4,5-dihydro-2H-pyridazin-3-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:102625-17-2 SDS

102625-17-2Upstream product

102625-17-2Relevant academic research and scientific papers

6-(4-Morpholino-phenyl)-4,5-dihydro-2H-pyridazine-3-ones: potent platelet aggregation inhibitors and antithrombotics

Goeschke, R,Gainer, J,Howarth, GA,Wallis, RB,Kerry, R,et al.

, p. 715 - 721 (2007/10/02)

A series of di- and tri-substituted 6-phenyl-4,5-dihydro-2H-pyridazine-3-ones is described.The compounds were designed to be antithrombotics and were assessed for their inhibitory properties on platelet aggregation and on thrombus formation in an arteriov

Substituted pyridazinones, pharmaceutical preparations containing these compounds, and the use thereof

-

, (2008/06/13)

The present invention relates to novel substituted pyridazinones of the general formula I STR1 wherein R is a halogen atom, a lower alkyl or lower alkoxy group, the nitro, hydroxyl, cyano, carboxyl, lower alkoxycarbonyl or carbamoyl group or the trifluoro

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 102625-17-2